Literature DB >> 17277935

Influence of nicotine on positive affect in anhedonic smokers.

Jessica Werth Cook1, Bonnie Spring, Dennis McChargue.   

Abstract

RATIONALE: The possibility that individuals administer nicotine to self-regulate persistent negative affect has received interest as a possible explanation for the high prevalence of affectively vulnerable smokers. Relatively overlooked, however, is the possibility that smokers might also self-administer nicotine to elevate low positive affect.
OBJECTIVES: This study examined whether nicotine administration augmented anhedonic smokers' positive affective response to a positive mood induction.
MATERIALS AND METHODS: Fifty regular smokers (50% female) underwent two positive mood inductions during which they smoked either a nicotinized or denicotinized cigarette in counterbalanced order. Positive affect was assessed before and at two time points after smoking.
RESULTS: Random effects regression showed a significant anhedonia by condition-by-time interaction [t(181)=-2.01, p = 0.04], supporting the hypothesis that anhedonia moderated nicotine's effect on changes in positive affect. Simple effect analyses showed a significant condition-by-time interaction among high anhedonic smokers [t(91)= 2.47, p = 0.01] but not among less anhedonic smokers [t(91)= 0.34, p = 0.73].
CONCLUSION: Smoking nicotine vs placebo heightened anhedonic smokers' ability to be induced into a positive mood, whereas nicotine had no effect on more hedonic smokers' positive mood.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277935     DOI: 10.1007/s00213-006-0688-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  44 in total

Review 1.  Primary and secondary hypohedonia.

Authors:  P E Meehl
Journal:  J Abnorm Psychol       Date:  2001-02

2.  Hedonic capacity: some conjectures.

Authors:  P E Meehl
Journal:  Bull Menninger Clin       Date:  1975-07

3.  Hedonic capacity, cigarette craving, and diminished positive mood.

Authors:  Jessica Werth Cook; Bonnie Spring; Dennis McChargue; Donald Hedeker
Journal:  Nicotine Tob Res       Date:  2004-02       Impact factor: 4.244

4.  Scales for physical and social anhedonia.

Authors:  L J Chapman; J P Chapman; M L Raulin
Journal:  J Abnorm Psychol       Date:  1976-08

5.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

6.  A system for administering quantified doses of tobacco smoke to human subjects: plasma nicotine and filter pad validation.

Authors:  D G Gilbert; R A Jensen; C J Meliska
Journal:  Pharmacol Biochem Behav       Date:  1988-12       Impact factor: 3.533

7.  Psychophysiologic assessment of posttraumatic stress disorder imagery in Vietnam combat veterans.

Authors:  R K Pitman; S P Orr; D F Forgue; J B de Jong; J M Claiborn
Journal:  Arch Gen Psychiatry       Date:  1987-11

8.  Positive and negative affectivity and their relation to anxiety and depressive disorders.

Authors:  D Watson; L A Clark; G Carey
Journal:  J Abnorm Psychol       Date:  1988-08

9.  Pharmacodynamic effects of new de-nicotinized cigarettes.

Authors:  W B Pickworth; R V Fant; R A Nelson; M S Rohrer; J E Henningfield
Journal:  Nicotine Tob Res       Date:  1999-12       Impact factor: 4.244

10.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09
View more
  48 in total

Review 1.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Where is the pleasure in that? Low hedonic capacity predicts smoking onset and escalation.

Authors:  Janet Audrain-McGovern; Daniel Rodriguez; Adam M Leventhal; Jocelyn Cuevas; Kelli Rodgers; Joseph Sass
Journal:  Nicotine Tob Res       Date:  2012-03-01       Impact factor: 4.244

Review 3.  Applying the tripartite model of anxiety and depression to cigarette smoking: an integrative review.

Authors:  Katherine J Ameringer; Adam M Leventhal
Journal:  Nicotine Tob Res       Date:  2010-10-29       Impact factor: 4.244

4.  Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers.

Authors:  Adam M Leventhal; Marcus Munafò; Jennifer W Tidey; Steve Sussman; John R Monterosso; Ping Sun; Christopher W Kahler
Journal:  Psychopharmacology (Berl)       Date:  2012-02-04       Impact factor: 4.530

5.  Do personality traits related to affect regulation predict other tobacco product use among young adult non-daily smokers?

Authors:  Kristin Brikmanis; Angela Petersen; Neal Doran
Journal:  Addict Behav       Date:  2017-07-10       Impact factor: 3.913

6.  Relations between anhedonia and smoking motivation.

Authors:  Adam M Leventhal; Andrew J Waters; Christopher W Kahler; Lara A Ray; Steve Sussman
Journal:  Nicotine Tob Res       Date:  2009-07-01       Impact factor: 4.244

7.  Anhedonia, depressed mood, and smoking cessation outcome.

Authors:  Adam M Leventhal; Megan E Piper; Sandra J Japuntich; Timothy B Baker; Jessica W Cook
Journal:  J Consult Clin Psychol       Date:  2013-11-11

8.  Anhedonia as a phenotypic marker of familial transmission of polysubstance use trajectories across midadolescence.

Authors:  Junhan Cho; Mattew D Stone; Adam M Leventhal
Journal:  Psychol Addict Behav       Date:  2018-11-19

Review 9.  Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model.

Authors:  Amanda R Mathew; Lee Hogarth; Adam M Leventhal; Jessica W Cook; Brian Hitsman
Journal:  Addiction       Date:  2016-10-26       Impact factor: 6.526

Review 10.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.